Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT

NCT02349178 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Leukemia, Acute Lymphoblastic
Acute Myeloid Leukemia

Interventions

DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Etoposide

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]